New Report Available: Romania Pharmaceuticals & Healthcare Report Q3 2015

From: Fast Market Research, Inc.
Published: Mon May 25 2015

We expect growth in pharmaceutical sales in 2015 to be primarily driven by Romania's improving macroeconomic outlook and a positive consumer story. We note that local regulatory factors such as revenue taxes will continue to present obstacles to growth. Rising clawback taxes and continued price cuts will be negative for the prescription drugs, hurting Romania's attractiveness to multinational drugmakers.

Headline Expenditure Projections

* Pharmaceuticals: RON14.17bn (USD4.28bn) in 2014 to RON14.75bn (USD3.62bn) in 2015; +4.1% in local currency terms and -15.3% in US dollar terms.
* Healthcare: RON34.69bn (USD10.47bn) in 2014 to RON36.38bn (USD8.93bn) in 2015; +4.9% in local currency terms and -14.7% in US dollar terms.

Risk/Reward Index

Romania has a BMI Risk & Reward Index (RRI) score of 56.2 out of 100, making it the fourth-most attractive pharmaceutical market in the Central and Eastern Europe (CEE) region. Romania has risen two places on our RRI since Q215, but this has been primarily due to a deterioration in the outlook for other closely-ranked CEE countries than due to a significant improvement for the pharmaceutical sector in Romania.

Full Report Details at

Key Trends And Developments

* In April 2015, Romania's National Agency for Medicines and Medical Devices President Marius Savu announced that prices of over 1,000 prescription medicines could be cut by 20% following an update of prices in the National Catalogue of Medicines. The new national catalogue, which is currently under public debate, could be effective from June 2015. About 40 new innovative drugs would be added to the updated catalogue. Further, the new list will update foreign exchange rate used for calculating drug prices.
* In March 2015, the US industry body Pharmaceutical Research and Manufacturers Association of America released its Special 301 Report on global concerns, highlighting the chronic underfunding of the healthcare system, barriers to market access, pharmaceutical pricing and...

The Romania Pharmaceuticals & Healthcare Report features BMI Research's forecasts for drugs and healthcare expenditure and imports and exports, focusing on the growth outlook for the prescription, OTC, patented drugs and generics market segments.

BMI's Romania Pharmaceuticals & Healthcare Report provides industry professionals, strategists, company executives, investors, analysts and sales/marketing heads with independent forecasts and competitive intelligence on the Romania pharmaceutical and healthcare industry.

Key Benefits

* Benchmark BMI's pharmaceutical and healthcare market forecasts for Romania, to test other views - a key input for successful budgeting and strategic business planning in the Romanian pharmaceutical and healthcare market.

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at or call us at 1.800.844.8156 (1.413.485.7001 Int'l)

You may also be interested in these related reports:

- South Korea Pharmaceuticals & Healthcare Report Q3 2015
- Jordan Pharmaceuticals & Healthcare Report Q3 2015
- Argentina Pharmaceuticals & Healthcare Report Q3 2015
- Central America Pharmaceuticals & Healthcare Report Q3 2015
- Colombia Pharmaceuticals & Healthcare Report Q3 2015

Company: Fast Market Research, Inc.
Contact Name: Bill Thompson
Contact Email:
Contact Phone: 1-413-485-7001

Visit website »